Opens in a new tab

Anumana Receives First and Only FDA Clearance for ECG-AI Cardiac Amyloidosis Algorithm Using a Standard 12-Lead ECG

Published Scientific Evidence

Anumana’s ECG-AI® technology is supported by one of the most extensive evidence bases in cardiovascular AI. This library provides direct access to our peer-reviewed validation studies and broader body of clinical research.

February
27
2019
{post_date: F d, Y}
Journal of Cardiovascular Electrophysiology

Prospective Validation of a Deep Learning Electrocardiogram Algorithm for the Detection of Left Ventricular Systolic Dysfunction

Patients undergoing routine ECG may have undetected left ventricular (LV) dysfunction that warrants further echocardiographic assessment. However, identification of these patients can be challenging. We applied the algorithm to all…
January
07
2019
{post_date: F d, Y}
Nature Medicine

Screening for cardiac contractile dysfunction using an artificial intelligence-enabled electrocardiogram

Asymptomatic left ventricular dysfunction (ALVD) is present in 3–6% of the general population, is associated with reduced quality of life and longevity, and is treatable when found,,,. An inexpensive, noninvasive…
February
28
2018
{post_date: F d, Y}
Journal of the Americal College of Cardiology (JACC) / ACC.18

Application Of Artificial Intelligence To The Standard 12 Lead Ecg To Identify People With Left Ventricular Dysfunction

Asymptomatic left ventricular dysfunction (ALVD) is present in 2-9% of the population, is associated with reduced longevity and is treatable when found. Inexpensive, reliable, in office screening is not available.…
August
31
2017
{post_date: F d, Y}
Journal of Electrocardiology

Noninvasive blood potassium measurement using signal-processed, single-lead ecg acquired from a handheld smartphone

We have previously used a 12-lead, signal-processed ECG to calculate blood potassium levels. We now assess the feasibility of doing so with a smartphone-enabled single lead, to permit remote monitoring.…
January
24
2016
{post_date: F d, Y}
Journal of the American Heart Association

Novel Bloodless Potassium Determination Using a Signal-Processed Single-Lead ECG

Hyper- and hypokalemia are clinically silent, common in patients with renal or cardiac disease, and are life threatening. A noninvasive, unobtrusive, blood-free method for tracking potassium would be an important…